Abstract:Positive resection margins occur in approximately 25% of breast cancer (BCa) surgeries, requiring re-operation. Margin status is not routinely available during surgery; thus, technologies that identify residual cancer on the specimen or cavity are needed to provide intraoperative decision support that may reduce positive margin rates. Rapid evaporative ionization mass spectrometry (REIMS) is an emerging technique that chemically profiles the plume generated by tissue cauterization to classify the ablated tissue as either cancerous or non-cancerous, on the basis of detected lipid species. Although REIMS can distinguish cancer and non-cancerous breast tissue by the signals generated, it does not indicate the location of the classified tissue in real-time. Our objective was to combine REIMS with spatio-temporal navigation (navigated REIMS), and to compare performance of navigated REIMS with conventional histopathology examination (gold standard) to assess margin status (positive or negative) in patients undergoing surgery for BCa. A multivariate model was trained using pathology-validated mass spectra from ex vivo resection specimens from 11 patients, including 36 spectra from invasive cancer, and 118 spectra from normal breast adipose. This model was subsequently tested retrospectively on intraoperative data from 25 BCa cases that were conducted using navigated REIMS. Navigation was facilitated by an electromagnetic sensor placed on the cautery. To record the position of the tumor, a localization wire fitted with an electromagnetic sensor was placed into the tumor using ultrasound prior to surgery, and a 3D map of the tumor was created. This enabled real-time knowledge of the cautery position relative to the tumor during surgery. Spectra from the plume classified as BCa were mapped onto a display of the tumor region and compared with the pathology report. Our multivariate classifier exhibited >90% accuracy on cross-validation, driven by an elevated ratio of glycerophospholipid:triglyceride in cancer as compared with normal adipose. In the intraoperative testing cohort, 4/150 margins were assessed by pathology as positive, all of which were correctly identified by REIMS (Sensitivity=100%). Notably, two of these cases were positive for ductal carcinoma in situ. 146/150 margins were negative, of which 131/146 negative margins were consistent with histopathology (Specificity=90%). There were 13 negative margins that were determined to be positive by REIMS (false positive), of which 8 margins were noted as either 'close margins' (with cancer cells being detected within 1 mm of the inked margin on histopathology), or as high-density normal breast tissue. Other normal tissue such as skin and muscle also exhibited high phospholipid content but these spectra could be rationalized by relative distance from the tumor region using the navigation data and/or information provided by the surgeon in real-time. We have demonstrated the importance of spatio-temporal tracking and histopathology to validate intraoperative REIMS. Furthermore, we have shown the feasibility of navigated REIMS in identifying margins containing cancer in real-time during BCa surgery, where a wider excision may be desirable. Citation Format: Martin Kaufmann, Amoon Jamzad, Tamas Ungi, Jessica R Rodgers, Teaghan Koster, Chris Yeung, Josh Ehrlich, Alice Santilli, Mark Asselin, Natasja Janssen, Julie McMullen, Kathryn Solberg, Joanna Cheesman, Alessia Di Carlo, Kevin Yi Mi Ren, Sonal Varma, Shaila Merchant, Cecil Jay Engel, G Ross Walker, Andrea Gallo, Doris Jabs, Parvin Mousavi, Gabor Fichtinger, John F Rudan. Three-dimensional navigated mass spectrometry for intraoperative margin assessment during breast cancer surgery [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl) nr PO2-23-07.

Three-Dimensional Histological Electrophoresis for High-Throughput Cancer Margin Detection in Multiple Types of Tumor Specimens

Three-dimensional histological electrophoresis enables fast automatic distinguishment of cancer margins and lymph node metastases

Analysis of Intraoperative Microscopy Imaging Techniques and Their Future Applications

A Pre-Screening Strategy to Assess Resected Tumor Margins by Imaging Cytoplasmic Viscosity and Hypoxia

Tumor Receptor-Seeking Dyes for Rapid Intraoperative Definition of Tumor Margin and Histopathological Morphology

A Handheld Fluorescence Molecular Tomography System for Intraoperative Optical Imaging of Tumor Margins.

Fast and label-free 3D virtual H&E histology via active modulation-assisted dynamic full-field OCT

Fluorescence-Guided Raman Spectroscopy for Tumour Margin Delineation

Evaluating the Margins of Breast Cancer Tumors by Using Digital Breast Tomosynthesis with Deep Learning: A Preliminary Assessment

Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology

Deformable Registration of Histological Cancer Margins to Gross Hyperspectral Images using Demons

Tumor margin detection using optical biopsy techniques

Label-free imaging of human brain tissue at subcellular resolution for potential rapid intra-operative assessment of glioma surgery

3D Spiral Channels Combined with Flexible Micro-Sieve for High-Throughput Rare Tumor Cell Enrichment and Assay from Clinical Pleural Effusion Samples

Abstract PO2-23-07: Three-dimensional navigated mass spectrometry for intraoperative margin assessment during breast cancer surgery

The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity

SENOSI Confocal Microscopy: A New and Innovating Way to Detect Positive Margins in Non-Palpable Breast Cancer?

An Integrated Microfluidic Device for Rapid and High-Sensitivity Analysis of Circulating Tumor Cells

Tracing Molecular Margins of Lung Cancer by Internal Extractive Electrospray Ionization Mass Spectrometry

Sputum-Based Tumor Fluid Biopsy: Isolation and High-Throughput Single-Cell Analysis of Exfoliated Tumor Cells for Lung Cancer Diagnosis

Low-cost Thermophoretic Profiling of Extracellular-Vesicle Surface Proteins for the Early Detection and Classification of Cancers